World's Best Scientists 2026 revealed!
Henry G. Grabowski

Henry G. Grabowski

D-Index & Metrics

Economics and Finance

D-Index
51
Citations
21036
World Ranking
1291
National Ranking
780

Henry G. Grabowski publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Henry G. Grabowski sits on this spectrum.

42–46 publications: 1 scientists 47–51 publications: 12 scientists 52–56 publications: 7 scientists 57–61 publications: 23 scientists 62–66 publications: 32 scientists 67–71 publications: 36 scientists 72–76 publications: 56 scientists 77–81 publications: 57 scientists 82–86 publications: 70 scientists 87–91 publications: 86 scientists 92–96 publications: 72 scientists 97–101 publications: 106 scientists 102–106 publications: 97 scientists 107–111 publications: 96 scientists 112–116 publications: 101 scientists 117–121 publications: 103 scientists 122–126 publications: 102 scientists 127–131 publications: 108 scientists 132–136 publications: 107 scientists 137–141 publications: 111 scientists 142–146 publications: 94 scientists 147–151 publications: 96 scientists 152–156 publications: 100 scientists 157–161 publications: 74 scientists 162–166 publications: 68 scientists 167–171 publications: 91 scientists 172–176 publications: 76 scientists 177–181 publications: 75 scientists 182–186 publications: 61 scientists 187–191 publications: 66 scientists 192–196 publications: 68 scientists 197–201 publications: 71 scientists 202–206 publications: 60 scientists 207–211 publications: 56 scientists 212–216 publications: 44 scientists 217–221 publications: 51 scientists 222–226 publications: 65 scientists 227–231 publications: 48 scientists 232–236 publications: 59 scientists 237–241 publications: 37 scientists 242–246 publications: 37 scientists 247–251 publications: 41 scientists 252–256 publications: 43 scientists 257–261 publications: 33 scientists 262–266 publications: 34 scientists 267–271 publications: 39 scientists 272–276 publications: 25 scientists 277–281 publications: 29 scientists 282–286 publications: 29 scientists 287–291 publications: 26 scientists 292–296 publications: 31 scientists 297–301 publications: 31 scientists 302–306 publications: 24 scientists 307–311 publications: 28 scientists 312–316 publications: 24 scientists 317–321 publications: 13 scientists 322–326 publications: 14 scientists 327–331 publications: 25 scientists 332–336 publications: 18 scientists 337–341 publications: 16 scientists 342–346 publications: 18 scientists 347–351 publications: 15 scientists 352–356 publications: 17 scientists 357–361 publications: 19 scientists 362–366 publications: 16 scientists 367–371 publications: 17 scientists 372–376 publications: 7 scientists 377–381 publications: 18 scientists 382–386 publications: 13 scientists 387–391 publications: 19 scientists 392–396 publications: 9 scientists 397–401 publications: 10 scientists 402–406 publications: 13 scientists 407–411 publications: 13 scientists 412–416 publications: 5 scientists 417–421 publications: 10 scientists 422–426 publications: 6 scientists 427–431 publications: 12 scientists 432–436 publications: 9 scientists 437–441 publications: 9 scientists 442–446 publications: 10 scientists 447–451 publications: 12 scientists 452–456 publications: 8 scientists 457–461 publications: 4 scientists 462–466 publications: 7 scientists 467–471 publications: 4 scientists 472–476 publications: 5 scientists 477–481 publications: 6 scientists 482–486 publications: 7 scientists 487–491 publications: 8 scientists 492–496 publications: 5 scientists 497–501 publications: 4 scientists 502–506 publications: 4 scientists 507–511 publications: 5 scientists 512–516 publications: 7 scientists 517–520 publications: 7 scientists 521+ publications: 99 scientists
42 publications 521+

This scientist: 139 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 521 publications or more.

Henry G. Grabowski D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Henry G. Grabowski sits on this spectrum.

30 D-Index: 126 scientists 31 D-Index: 147 scientists 32 D-Index: 157 scientists 33 D-Index: 178 scientists 34 D-Index: 171 scientists 35 D-Index: 141 scientists 36 D-Index: 132 scientists 37 D-Index: 129 scientists 38 D-Index: 130 scientists 39 D-Index: 120 scientists 40 D-Index: 117 scientists 41 D-Index: 113 scientists 42 D-Index: 114 scientists 43 D-Index: 97 scientists 44 D-Index: 115 scientists 45 D-Index: 86 scientists 46 D-Index: 78 scientists 47 D-Index: 83 scientists 48 D-Index: 62 scientists 49 D-Index: 74 scientists 50 D-Index: 50 scientists 51 D-Index: 66 scientists 52 D-Index: 69 scientists 53 D-Index: 55 scientists 54 D-Index: 67 scientists 55 D-Index: 61 scientists 56 D-Index: 62 scientists 57 D-Index: 45 scientists 58 D-Index: 34 scientists 59 D-Index: 47 scientists 60 D-Index: 46 scientists 61 D-Index: 36 scientists 62 D-Index: 37 scientists 63 D-Index: 56 scientists 64 D-Index: 50 scientists 65 D-Index: 32 scientists 66 D-Index: 28 scientists 67 D-Index: 30 scientists 68 D-Index: 24 scientists 69 D-Index: 25 scientists 70 D-Index: 22 scientists 71 D-Index: 21 scientists 72 D-Index: 26 scientists 73 D-Index: 24 scientists 74 D-Index: 23 scientists 75 D-Index: 12 scientists 76 D-Index: 14 scientists 77 D-Index: 15 scientists 78 D-Index: 15 scientists 79 D-Index: 17 scientists 80 D-Index: 17 scientists 81 D-Index: 11 scientists 82 D-Index: 10 scientists 83 D-Index: 16 scientists 84 D-Index: 11 scientists 85 D-Index: 5 scientists 86 D-Index: 9 scientists 87 D-Index: 13 scientists 88 D-Index: 9 scientists 89 D-Index: 7 scientists 90 D-Index: 6 scientists 91 D-Index: 4 scientists 92 D-Index: 8 scientists 93 D-Index: 10 scientists 94 D-Index: 11 scientists 95 D-Index: 6 scientists 96 D-Index: 4 scientists 97 D-Index: 4 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100 D-Index: 8 scientists 101+ D-Index: 100 scientists
30 D-Index 101+

This scientist: 51 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 101 D-Index or more.

Overview

Henry G. Grabowski is affiliated with Duke University in the United States and specializes in research within the fields of Economics, Econometrics and Finance. The primary subfields of their work include Economics and Econometrics, Pharmacology, and Pulmonary and Respiratory Medicine.

The scientist's research topics focus extensively on Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, and Quality of Life issues. Additional areas of study cover the Pharmaceutical industry and healthcare, Economic and Financial Impacts of Cancer, Innovation Policy and R&D, as well as Cystic Fibrosis Research Advances.

Henry G. Grabowski has published articles in several academic journals with a notable concentration in the Journal of Medical Economics and Health Affairs, as well as a contribution to the Journal of Cystic Fibrosis. The recent publications include:

  • "Continuing trends in U.S. brand-name and generic drug competition", 2021, Journal of Medical Economics
  • "Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act", 2024, Health Affairs
  • "Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act", 2024, Journal of Medical Economics
  • "Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerations", 2024, Journal of Medical Economics (co-authored)
  • "503 Perceptions of treatment burden for people with cystic fibrosis on highly effective modulator therapy after a withdrawal study", 2023, Journal of Cystic Fibrosis (co-authored)

Collaboration plays a role in their research, with frequent co-authors including Genia Long (4 publications), Joseph A. DiMasi (2 publications), Richard Mortimer, Mehmet Bilginsoy, and David Proudman, the latter three contributing to at least one publication each.

The scope of Henry G. Grabowski's work centers on analyzing economic and policy implications in pharmaceutical sectors, particularly focusing on drug competition, innovation in oncology drugs, and regulatory impacts such as those related to the US Inflation Reduction Act. Their cross-disciplinary approach integrates economic evaluations with health system and disease-specific research including cystic fibrosis and cardiovascular drug trials.

Best Publications

  • The price of innovation: new estimates of drug development costs

    Joseph A. DiMasi;Ronald W. Hansen;Henry G. Grabowski

  • Innovation in the pharmaceutical industry: New estimates of R&D costs

    Joseph A. DiMasi;Henry G. Grabowski;Ronald W. Hansen

  • Cost of innovation in the pharmaceutical industry.

    Joseph A DiMasi;Ronald W Hansen;Henry G Grabowski;Louis Lasagna

  • The cost of biopharmaceutical R&D: is biotech different?

    Joseph A. DiMasi;Henry G. Grabowski

  • Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act

    Henry G. Grabowski;John M. Vernon

  • A New Look at the Returns and Risks to Pharmaceutical R&D

    Henry Grabowski;John Vernon

  • Economics of New Oncology Drug Development

    Joseph A. DiMasi;Henry G. Grabowski

  • Returns on Research and Development for 1990s New Drug Introductions

    Henry Grabowski;John Vernon;Joseph A. DiMasi

  • Industrial Research and Development, Intangible Capital Stocks, and Firm Profit Rates

    Henry G. Grabowski;Dennis C. Mueller

  • Returns to R&D on new drug introductions in the 1980s

    Henry G Grabowski;John M Vernon

  • The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries

    Unknown

  • Developing Drugs For Developing Countries

    David B. Ridley;Henry G. Grabowski;Jeffrey L. Moe

  • Generic competition and market exclusivity periods in pharmaceuticals

    Henry G. Grabowski;Margaret Kyle

  • Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program

    Jennifer S. Li;Eric L. Eisenstein;Henry G. Grabowski;Elizabeth D. Reid

  • Managerial and Stockholder Welfare Models of Firm Expenditures

    Henry G. Grabowski;Dennis C. Mueller

  • Longer patents for increased generic competition in the US. The Waxman-Hatch Act after one decade.

    Henry Grabowski;John Vernon

  • Patents, Innovation and Access to New Pharmaceuticals

    Henry Grabowski

  • Generic Competition in the US Pharmaceutical Industry

    Atanu Saha;Henry Grabowski;Howard Birnbaum;Paul Greenberg

  • Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

    Joseph A. DiMasi;Ronald W. Hansen;Henry C. Grabowski;Louis Lasagna

  • International public goods and transfer of technology under a globalized intellectual property regime

    Keith E. Maskus;Jerome H. Reichman

  • Estimating the effects of regulation on innovation: an international comparative analysis of the pharmaceutical industry.

    Henry G. Grabowski;John M. Vernon;Lacy Glenn Thomas

  • R&D Costs and Returns by Therapeutic Category

    Joseph A DiMasi;Henry G Grabowski;John M Vernon

  • The determinants of pharmaceutical research and development expenditures

    Henry Grabowski;John Vernon

Frequent Co-Authors

Dennis C. Mueller
Dennis C. Mueller University of Vienna
Frank A. Sloan
Frank A. Sloan Duke University
Gary A. Zarkin
Gary A. Zarkin Research Triangle Park Foundation
W. Kip Viscusi
W. Kip Viscusi Vanderbilt University
Tracy R. Lewis
Tracy R. Lewis Duke University
William N. Evans
William N. Evans University of Notre Dame
Iain M. Cockburn
Iain M. Cockburn Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Economics and Finance opens doors to a variety of career paths, and many students explore related fields through online programs for greater flexibility and affordability. For those interested in management roles within the hospitality sector, a fast track hospitality management degree can be an efficient way to gain industry-specific leadership skills.

If you're seeking advanced business knowledge, consider enrolling in affordable aacsb-accredited online mba programs. These programs are recognized for their quality and can significantly enhance your career prospects in both finance and broader business environments.

Human resource management is another field closely tied to finance and organizational success. The best hr master's programs online help build skills in workforce planning, talent management, and employee relations—expertise in high demand across industries.

Finally, clear communication is essential in both economics and finance. A masters in communication online can provide advanced strategies for conveying complex ideas and reports, supporting leadership roles in financial organizations.

Best Scientists Citing Henry G. Grabowski

Trending Scientists

Recently Published Articles